LANSOPRAZOL 30 MG CAP GEL DURA MCGRAN LIB RETARD CT BL AL PLAS INC X 14

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1256802110022
  • GGREM 528530401111118
  • Código de barras 7899547505429

O que a fonte publica

Detentor do registro
PRATI DONADUZZI & CIA LTDA
Princípios ativos
LANSOPRAZOL
Embalagem
30 MG CAP GEL DURA MCGRAN LIB RETARD CT BL AL PLAS INC X 14
Tipo de produto
Genérico
Classe terapêutica
A2B2 - INIBIDORES DA BOMBA DE PRÓTONS

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:528530401111118
{
  "name": "LANSOPRAZOL 30 MG CAP GEL DURA MCGRAN LIB RETARD CT BL AL PLAS INC X 14",
  "holder": "PRATI DONADUZZI & CIA LTDA",
  "stripe": null,
  "barcodes": [
    "7899547505429"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "528530401111118",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "73.856.593/0001-66",
  "priceRegime": "Regulado",
  "productName": "LANSOPRAZOL",
  "productType": "Genérico",
  "hospitalOnly": false,
  "presentation": "30 MG CAP GEL DURA MCGRAN LIB RETARD CT BL AL PLAS INC X 14",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "59.76",
    "icms-12": "67.91",
    "icms-17": "72.00",
    "icms-18": "72.88",
    "icms-19": "73.78",
    "icms-20": "74.70",
    "icms-21": "75.65",
    "icms-22": "76.62",
    "icms-23": "77.61",
    "icms-17.5": "72.44",
    "icms-19.5": "74.24",
    "icms-20.5": "75.17",
    "icms-22.5": "77.11",
    "icms-12-alc": "67.09",
    "icms-17-alc": "71.14",
    "icms-18-alc": "72.00",
    "icms-19-alc": "72.89",
    "icms-20-alc": "73.80",
    "icms-21-alc": "74.74",
    "icms-22-alc": "75.70",
    "icms-23-alc": "76.68",
    "withoutTaxes": "59.04",
    "icms-17.5-alc": "71.57",
    "icms-19.5-alc": "73.35",
    "icms-20.5-alc": "74.27",
    "icms-22.5-alc": "76.18"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "LANSOPRAZOL",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "82.37",
    "icms-12": "93.61",
    "icms-17": "99.24",
    "icms-18": "100.46",
    "icms-19": "101.70",
    "icms-20": "102.97",
    "icms-21": "104.28",
    "icms-22": "105.61",
    "icms-23": "106.98",
    "icms-17.5": "99.85",
    "icms-19.5": "102.33",
    "icms-20.5": "103.61",
    "icms-22.5": "106.29",
    "icms-12-alc": "92.75",
    "icms-17-alc": "98.35",
    "icms-18-alc": "99.54",
    "icms-19-alc": "100.77",
    "icms-20-alc": "102.02",
    "icms-21-alc": "103.32",
    "icms-22-alc": "104.65",
    "icms-23-alc": "106.01",
    "withoutTaxes": "81.62",
    "icms-17.5-alc": "98.94",
    "icms-19.5-alc": "101.40",
    "icms-20.5-alc": "102.67",
    "icms-22.5-alc": "105.31"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "LANSOPRAZOL"
  ],
  "therapeuticClass": "A2B2 - INIBIDORES DA BOMBA DE PRÓTONS",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1256802110022",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "A2B2",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:528530401111118"